CervoMed Inc. (NASDAQ: CRVO) Stock Information | RedChip

CervoMed Inc. (NASDAQ: CRVO)


$2.3200
+0.0900 ( +5.46% ) 135.6K

CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.

Market Data


Open


$2.3200

Previous close


$2.2300

Volume


135.6K

Market cap


$19.20M

Day range


$2.1810 - $2.3470

52 week range


$1.8000 - $26.3789

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
4 Insider transactions 1 Jun 14, 2024
8-k 8K-related 19 May 20, 2024
8-k 8K-related 16 May 15, 2024
10-q Quarterly Reports 63 May 14, 2024
def Proxies and info statements 9 Apr 29, 2024
8-k 8K-related 14 Apr 23, 2024
8-k 8K-related 16 Apr 05, 2024

Latest News